Pfizer Inc - Company Snapshot & SWOT Analysis

Publication ID:

NAV0319004

Publication Date:

March 06, 2019

Pages:

Countries:

Global [1]

As per NAVADHI Market Research, the global pharmaceutical industry [2] will we worth USD 1.57 trillion by 2023.

Pfizer Inc. is a research-based, global biopharmaceutical company headquartered in New York City, with its research headquarters in Groton, their global portfolio includes medicines and vaccines, as well as many of the world’s best-known consumer healthcare products. Pfizer work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases on time.

Pfizer Inc. 2018 Revenue Performance at a glance

Their revenues are derived from the sale of their products and, to a much lesser extent, from alliance agreements, under which they co-promote products discovered or developed by other companies or us. The majority of their revenues come from the manufacture and sale of biopharmaceutical products. The Company was incorporated under the laws of the State of Delaware on June 2, 1942.

Pfizer's full-year 2018 revenues totaled $53.6 billion, an increase of $1.1 billion, or 2%, compared to full-year 2017, reflecting operational growth of $791 million, or 2%, and the favorable impact of foreign exchange of $310 million, or less than 1%.

According to Pfizer's 2019 financial guidance, company anticipates continued strong growth from key product franchises, including Ibrance, Eliquis, Xeljanz and Xtandi as well as the expected loss of exclusivity of Lyrica in the U.S. in June 2019.

Spanning over 29 pages and 10 exhibits, “Pfizer Inc - Company Snapshot & SWOT Analysis” report provides value chain analysis, financial performance, business strategy and SWOT analysis for company.

Scope of the Pfizer Inc- Company Snapshot & SWOT Analysis Report

This report provides detailed information about Pfizer Inc. including value chain analysis, financial performance, business strategy and SWOT analysis.
he report identifies the growth drivers and inhibitors for global pharmaceutical market.
This report provides information about current and future trends for global pharmaceutical market.

1. Executive Summary

Scope of the Pfizer Inc.- Company Snapshot & SWOT Analysis Report

Research Methodology

2. Growth Drivers and Inhibitors for Global Pharmaceuticals Market

3. Company Profile

3.1 Pfizer Inc.

3.1.1. Company Profile

3.1.2 Pfizer Inc. in Global Pharmaceuticals Manufacturing Value Chain

3.1.3 Pfizer Inc.: Financial Performance

3.1.3.1 Pfizer Inc.: Overall Revenue FY 2013-FY 2019 (in USD billion)

3.1.3.2 Pfizer Inc.: Geography-Wise Revenue FY 2018 (in USD billion)

3.1.3.3 Pfizer Inc.: Therapy Area-Wise Revenue FY 2018 (in USD billion)

3.1.4 Pfizer Inc.: Business Strategy

3.1.4.1 Product Level Strategy

3.1.5 SWOT Analysis of Pfizer Inc.

Strengths

Weaknesses

Opportunities

Threats

4. Current and Future Trends in Pharmaceutical Market

List of Exhibits

Notes

List of Exhibits

Exhibit 2.1 Growth Drivers and Inhibitors for Global Pharmaceuticals Market

Exhibit 3.1 Key Information of Pfizer Inc.

Exhibit 3.2 Contact information of Pfizer Inc.

Exhibit 3.3 Pfizer Inc. in Pharmaceuticals Manufacturing Value Chain

Exhibit 3.4 Revenue of Pfizer Inc. FY 2013- FY 2019 (in USD billion)

Exhibit 3.5 Revenue Growth of Pfizer Inc. FY 2014- FY 2019 (in %)

Exhibit 3.6 Geography-Wise Revenue of Pfizer Inc. in FY 2018 (in USD billion)

Exhibit 3.7 Therapy Area-Wise Revenue of Pfizer Inc. in FY 2018 (in USD billion)

Exhibit 3.8 Therapy and Geography Area-Wise Revenue of Pfizer Inc. FY 2018 (in USD billion)

Exhibit 3.9 SWOT Analysis of Pfizer Inc.

Pfizer Inc.

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Enterprise license fee.

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Enterprise license fee.

Enterprise License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.